Hitting the target: new treatments for cystic fibrosis.
暂无分享，去创建一个
[1] R. Boucher. Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. , 2007, Annual review of medicine.
[2] Mark R Elkins,et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. , 2006, The New England journal of medicine.
[3] P. Negulescu,et al. Rescue of the protein folding defect in cystic fibrosis in vitro by the investigational small molecule, VX-809 , 2010 .
[4] R. Gibson,et al. Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: Results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis , 2005, Pediatric pulmonology.
[5] G. Retsch-Bogart. Update on new pulmonary therapies , 2009, Current opinion in pulmonary medicine.
[6] Jinglan Zhou,et al. Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770 , 2009, Proceedings of the National Academy of Sciences.
[7] S. Anderson,et al. Inhaled mannitol improves lung function in cystic fibrosis. , 2008, Chest.
[8] M. Knowles,et al. 'CFTR-opathies': disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations , 2001, Respiratory research.